HK1055462A1 - Identification of viral agents in breast ducts andantiviral therapy therefore - Google Patents

Identification of viral agents in breast ducts andantiviral therapy therefore

Info

Publication number
HK1055462A1
HK1055462A1 HK03107628A HK03107628A HK1055462A1 HK 1055462 A1 HK1055462 A1 HK 1055462A1 HK 03107628 A HK03107628 A HK 03107628A HK 03107628 A HK03107628 A HK 03107628A HK 1055462 A1 HK1055462 A1 HK 1055462A1
Authority
HK
Hong Kong
Prior art keywords
therapy
andantiviral
identification
breast
viral agents
Prior art date
Application number
HK03107628A
Other languages
English (en)
Inventor
David Hung
Original Assignee
Cytyc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytyc Corp filed Critical Cytyc Corp
Publication of HK1055462A1 publication Critical patent/HK1055462A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK03107628A 2000-08-08 2003-10-22 Identification of viral agents in breast ducts andantiviral therapy therefore HK1055462A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22385700P 2000-08-08 2000-08-08
PCT/US2001/024770 WO2002012900A1 (fr) 2000-08-08 2001-08-08 Identification d'agents viraux dans des conduits d'un sein et therapie antivirale correspondante

Publications (1)

Publication Number Publication Date
HK1055462A1 true HK1055462A1 (en) 2004-01-09

Family

ID=22838235

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03107628A HK1055462A1 (en) 2000-08-08 2003-10-22 Identification of viral agents in breast ducts andantiviral therapy therefore

Country Status (9)

Country Link
US (2) US7132232B2 (fr)
EP (1) EP1307746B1 (fr)
JP (1) JP2004505621A (fr)
AT (1) ATE360209T1 (fr)
AU (2) AU2001281161B2 (fr)
DE (1) DE60127965T2 (fr)
ES (1) ES2284672T3 (fr)
HK (1) HK1055462A1 (fr)
WO (1) WO2002012900A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110609A1 (en) * 1998-12-28 2002-08-15 David Hung Increasing retrievable fluid from a breast duct
WO2000043550A2 (fr) 1999-01-21 2000-07-27 Wayne State University Procede et dispositif permettant le dosage de facteurs dans le fluide mammaire
EP1185309B1 (fr) * 1999-06-11 2006-10-04 Cytyc Corporation Composition liquide de gel pour remplir un canal galactophore d'un sein avant une ablation chirurgicale de ce canal ou d'autres tissus mammaires
JP2004505621A (ja) * 2000-08-08 2004-02-26 シーワイティーワイシー　ヘルス　コーポレイション 乳管におけるウイルス物質の同定方法およびそれに伴う抗ウイルス療法
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
US6866994B2 (en) * 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
AU2005280528B2 (en) * 2004-07-30 2010-12-23 Adeza Biomedical Corporation Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169774A (en) 1984-02-08 1992-12-08 Cetus Oncology Corporation Monoclonal anti-human breast cancer antibodies
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
WO1989006692A1 (fr) 1988-01-12 1989-07-27 Genentech, Inc. Procede de traitement de cellules tumorales par inhibition de la fonction receptrice du facteur de croissance
IT1251542B (it) 1991-03-06 1995-05-17 D D S R L Dispositivo per il lavaggio a scopo terapeutico o di igiene di condotti interni del corpo umano o animale, che consente il drenaggio del liquido di lavaggio
US5763415A (en) * 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
US6221622B1 (en) 1998-04-28 2001-04-24 The Regents Of The University Of California Method and kit for obtaining fluids and cellular material from breast ducts
US6413228B1 (en) 1998-12-28 2002-07-02 Pro Duct Health, Inc. Devices, methods and systems for collecting material from a breast duct
US6638727B1 (en) 1999-01-26 2003-10-28 Cytyc Health Corporation Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
JP2003535617A (ja) 1999-03-01 2003-12-02 プロ ダクト ヘルス インコーポレーティッド 多数の乳管に物質を同時に送達するための装置、方法、およびキット
JP2004505621A (ja) * 2000-08-08 2004-02-26 シーワイティーワイシー　ヘルス　コーポレイション 乳管におけるウイルス物質の同定方法およびそれに伴う抗ウイルス療法

Also Published As

Publication number Publication date
US7132232B2 (en) 2006-11-07
ATE360209T1 (de) 2007-05-15
JP2004505621A (ja) 2004-02-26
AU2001281161B2 (en) 2007-08-23
EP1307746B1 (fr) 2007-04-18
US20020045162A1 (en) 2002-04-18
US20070009946A1 (en) 2007-01-11
DE60127965T2 (de) 2007-12-20
US7405045B2 (en) 2008-07-29
AU8116101A (en) 2002-02-18
WO2002012900A1 (fr) 2002-02-14
ES2284672T3 (es) 2007-11-16
DE60127965D1 (de) 2007-05-31
EP1307746A1 (fr) 2003-05-07

Similar Documents

Publication Publication Date Title
BR0111195A (pt) Uso de b-l-2'-desoxi-nucleosìdeos no tratamento de infecção por vìrus de hepatite delta
CY2016021I2 (el) Στελεχη ιων για την ογκολυτικη θεραπεια του καρκινου
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
BR9913935A (pt) Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
EP1109580A4 (fr) Methodes de traitement ou de prevention des infections virales et des maladies associees
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
DE60020529D1 (de) Antikörper zur krebsbehandlung und -diagnose
BR9912653A (pt) Vìrus de herpes atenuado, cepa de vìrus, célula dendrìtica, processo para produzir um célula, composição farmacêutica, uso de um vìrus, e, processo para executar a terapia de gene em um paciente humano ou animal ou para tratar ou prevenir uma infecção patogênica ou câncer para tratar paciente animal
BR9712366A (pt) Gene de gd2 do vírus do herpes simples hsv2 isolado, plasmídeo compreendendo o mesmo, e, processos de induzir, em indivíduo, uma resposta imune contra hsv2 gd2, de tratar um indíviduo que está infectado com hsv, e, de prevenir que um indivíduo fique infectado com hsv
SE9602931L (sv) Ny medicinsk användning
ATE402713T1 (de) Genetisch manipulierte herpesviren zur behandlung von tumoren
HK1055462A1 (en) Identification of viral agents in breast ducts andantiviral therapy therefore
AR006023A1 (es) Vacuna contra el sindrome reproductivo y respiratorio porcino
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
DE68912155D1 (de) Antivirales Kombinationspräparat.
DE60129358D1 (de) Genetische immunisierung gegen zervixkarzinom
NO20041855L (no) Fremgangsmate for behandling av hepatitt C-virusinfeksjon ved behandling av feilpasienter
EP1785727A3 (fr) Identification d'agents viraux dans les conduits du sein et thérapie antivirale correspondante
NO20012634D0 (no) Nye kreftbehandlinger
MY124071A (en) Treatment of viral disease in swine
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ATE356144T1 (de) Regulatorische/entfaltende peptide von ezrin
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
PT979093E (pt) Agente viral terapeutico que interrompe o desenvolvimento de tumores

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: CYTYC CORPORATION

Free format text: FORMER OWNER(S): CYTYC HEALTH CORPORATION

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160808